2026 NPPES data Pharmacist NPI 1780346601 PHARMD
Verify on CMS →

AKINMUSUYI OLADIRAN, PHARMD

Pharmacist in LEWISTON, Idaho. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
480
Medicare Part D claims · 65 beneficiaries · Pharmacist avg: 135
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

AKINMUSUYI OLADIRAN, PHARMD filed 480 Medicare Part D claims in 2023 as a Pharmacist in LEWISTON, Idaho, prescribing 41% generic.

480
Part D claims, 2023
41%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AKINMUSUYI OLADIRAN, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

480 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about AKINMUSUYI OLADIRAN, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 10/07/2021

NPI 1780346601

Primary specialty

Pharmacist

High-volume

290,447 US NPIs in this specialty

Medicare Part D claims

480 256% vs specialty avg

2023 prescription claims

Specialty avg: 135

Specialty distribution in Idaho

How Pharmacist compares to other specialties among Idaho providers

Idaho providers

Pharmacist share within Idaho

1. Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist share within Idaho

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AKINMUSUYI OLADIRAN, PHARMD appears in the CMS NPPES registry as a Pharmacist provider holding PHARMD credentials at 1203 IDAHO ST, LEWISTON, ID, 83501, with a listed phone of (509) 444-8200. NPI 1780346601 was issued on 10/07/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what OLADIRAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 480 prescription claims written by this provider, covering 65 Medicare beneficiaries and totaling roughly $312K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist is a high-volume specialty nationwide, with 290,447 enrolled providers across 56 states and an average of 135 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1203 IDAHO ST
LEWISTON, ID 83501

Provider Details

NPI 1780346601
Specialty Pharmacist
Credentials PHARMD
Gender Male
NPI Issued 10/07/2021

Brand vs generic prescribing mix · Brand-heavy

AKINMUSUYI OLADIRAN, PHARMD — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 480 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

480
Total Claims
$312K
Total Drug Cost
65
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
819
Total Day Supply
24,383
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$309K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
62.9 years
Avg HCC Risk Score
1.83
Gender Split
52% female / 48% male
Age Distribution
<65: 32, 65-74: 26, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AKINMUSUYI OLADIRAN, PHARMD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trulicity
Dulaglutide
71
Jardiance
Empagliflozin
46
Victoza 3-Pak
Liraglutide
33
Ozempic
Semaglutide
28
Glimepiride
23
Metformin Hcl Er
Metformin Hcl
23
Warfarin Sodium
18
Atorvastatin Calcium
17
Novolog Flexpen
Insulin Aspart
14
Metformin Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Overview

How AKINMUSUYI OLADIRAN, PHARMD fits within the Pharmacist landscape nationally.

290,447
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider

AKINMUSUYI OLADIRAN, PHARMD's 480 claims are above the specialty average of 135.

Nearby Pharmacist Providers in Idaho

Other clinicians with the same primary specialty enrolled in Idaho, drawn from the same CMS NPPES roster as OLADIRAN.

Compare Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is AKINMUSUYI OLADIRAN, PHARMD's specialty?
AKINMUSUYI OLADIRAN, PHARMD specializes in Pharmacist and practices in LEWISTON, Idaho. Credentials: PHARMD.
How much does AKINMUSUYI OLADIRAN, PHARMD prescribe under Medicare Part D?
In 2023, AKINMUSUYI OLADIRAN, PHARMD wrote 480 Medicare Part D claims totaling $312K in drug costs for 65 beneficiaries.
Where is AKINMUSUYI OLADIRAN, PHARMD located?
AKINMUSUYI OLADIRAN, PHARMD is located at 1203 IDAHO ST, LEWISTON, ID, 83501. Phone: (509) 444-8200.
What is AKINMUSUYI OLADIRAN, PHARMD's NPI number?
AKINMUSUYI OLADIRAN, PHARMD's National Provider Identifier (NPI) is 1780346601, issued on 10/07/2021.
Does AKINMUSUYI OLADIRAN, PHARMD prescribe more brand-name or generic drugs?
AKINMUSUYI OLADIRAN, PHARMD's prescribing is 59% brand-name and 41% generic drugs by claim count, with $309K in brand drug costs.
How many Pharmacist providers are there in the US?
There are 290,447 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does AKINMUSUYI OLADIRAN, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, AKINMUSUYI OLADIRAN, PHARMD's most frequently prescribed drugs include Trulicity, Jardiance, Victoza 3-Pak. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AKINMUSUYI OLADIRAN, PHARMD accept Medicare?
AKINMUSUYI OLADIRAN, PHARMD appears in CMS Medicare data with 480 Part D claims and 65 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AKINMUSUYI OLADIRAN, PHARMD's credentials?
AKINMUSUYI OLADIRAN, PHARMD's NPI is 1780346601 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology